Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Delta Hepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07491848
What this trial is testing

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

Who this might be right for
HEPATITIS B CHRONICHepatitis DPeriodontitis
Research Center of Periodontal-Systemic Interactions 25
Not applicableStudy completedNCT07116044
What this trial is testing

Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection

Who this might be right for
Evaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients
University of Molise 160
Not applicableUnknownNCT04170452
What this trial is testing

Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta

Who this might be right for
Chronic Hepatitis DeltaLiver Biopsy
Tokhirbek Dolimov 30
Not applicableStudy completedNCT01107483
What this trial is testing

Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Sun Yat-sen University 140
Early research (Phase 1)Looking for participantsNCT07610772
What this trial is testing

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

Who this might be right for
Hepatitis D, ChronicHepatitis B Chronic Infection
Aarhus University Hospital 15
Large-scale testing (Phase 3)Study completedNCT05229991
What this trial is testing

Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection

Who this might be right for
Hepatitis D, Chronic
Soroka University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00001457
What this trial is testing

Lamivudine for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BChronic Hepatitis DGlomerulonephritis+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Not applicableLooking for participantsNCT06638320
What this trial is testing

Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis Delta With Hepatitis B Carrier StateChronic Hepatitis b
Tam Anh Research Institute 2,452
Not applicableStudy completedNCT03158818
What this trial is testing

Chronic Hepatitis B Virus Infection in Zambia

Who this might be right for
HBVFibrosis, LiverCirrhosis, Liver+3 more
University of Alabama at Birmingham 326
Testing effectiveness (Phase 2)Study completedNCT03546621
What this trial is testing

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

Who this might be right for
Chronic Hepatitis D Infection With Hepatitis B
Hepatera Ltd. 120
Early research (Phase 1)Study completedNCT04638439
What this trial is testing

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Who this might be right for
Chronic Hepatitis B InfectionChronic Hepatitis D Infection
PharmaEssentia 20
Large-scale testing (Phase 3)Study completedNCT02732639
What this trial is testing

Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 31
Not applicableUnknownNCT05928000
What this trial is testing

HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV

Who this might be right for
Hepatitis D
University of Athens 80
Early research (Phase 1)Study completedNCT05760300
What this trial is testing

A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function

Who this might be right for
Chronic Hepatitis D Infection
Gilead Sciences 41
Not applicableStudy completedNCT05723068
What this trial is testing

Burden of Hepatitis D Virus (HDV) Infection in Italy

Who this might be right for
Chronic Hepatitis D
University of Turin, Italy 515
Testing effectiveness (Phase 2)Study completedNCT02731131
What this trial is testing

Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT07309380
What this trial is testing

Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Who this might be right for
Hepatitis D, Chronic
Shanghai HEP Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT03852433
What this trial is testing

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Who this might be right for
Chronic Hepatitis Delta
Gilead Sciences 175
Large-scale testing (Phase 3)Looking for participantsNCT07499544
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

Who this might be right for
Chronic Hepatitis D Infection
Huahui Health 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07762027
What this trial is testing

Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection

Who this might be right for
Chronic Hepatitis D Infection
Assembly Biosciences 80
Next Page